Tag: Drug safety alerts

Pharma – Asia, S America, MENA, ROW Regulatory News – Sept 2025

Biopharma

AUSTRALIA TGA Updates Permissible Ingredients for Listed Medicines Australia’s Therapeutic Goods Administration (TGA) has released Determination No. 3 of 2025, effective 19 September. This update...

ANVISA, drug recall, Drug safety alerts, Global pharmaceutical compliance, meta description, NAFDAC alert, NMPA, Pharma Regulatory News, pharmaceutical campaign, PMDA, Regulatory Intelligence, SAHPRA, TGA updates

Pharma- Asia, S America, MENA, ROW Regulatory News – July 2025

Biopharma

ARGENTINA ANMAT Opens Public Consultation on ICH E20 Guideline for Adaptive Clinical Trials The National Administration of Drugs, Food and Medical Technology (ANMAT) has opened a public consultation...

ANMAT guidelines, CDSCO digital submission, Clinical trial regulations, Drug safety alerts, Global pharmaceutical compliance, GMP extensions, July 2025 updates, Pharma Regulatory News, Regulatory harmonization, TGA compliance